ABIVAX (EPA:ABVX) | WebDisclosure

Basculer en Français

9479	Companies
185504	Keywords
117879	Articles
99354	Press releases

Home
Companies
ABIVAX

PRESS RELEASE

published on 10/03/2025 at 11:54, 2 months 2 days ago

Franchissement de seuil
JP Morgan Chase & Co. notifies increase to 5.64% voting rights in ABIVAX via indirect ownership. Details provided in threshold crossing declaration under article L. 233-7 of French Commercial Code

Abivax JP Morgan Chase Article L. 233-7 5.64% Threshold Crossing Declaration
BRIEF

published on 09/29/2025 at 22:10, 2 months 5 days ago

Abivax présente de nouvelles découvertes sur l'obéfazimod à l'UEG 2025

Abivax Obefazimod Rectocolite Hémorragique Essais De Phase 3 Réunion De L'UEG
BRIEF

published on 09/29/2025 at 22:10, 2 months 5 days ago

Abivax Presents New Findings on Obefazimod at UEG 2025

Abivax Obefazimod Ulcerative Colitis Phase 3 Trials UEG Meeting
PRESS RELEASE

published on 09/29/2025 at 22:05, 2 months 5 days ago

Abivax annonce l’acceptation d’un « late-breaking » abstract supplémentaire sur les essais d'induction ABTECT de phase 3, qui sera présenté à l'occasion de la semaine United European Gastroenterology
Abivax annonce l'acceptation d'un nouvel abstract sur les essais d'induction ABTECT de phase 3 pour la rectocolite hémorragique modérément à sévèrement active, à présenter à la semaine UEG

Abivax Rectocolite Hémorragique ABTECT UEG Essais D'induction
PRESS RELEASE

published on 09/29/2025 at 22:05, 2 months 5 days ago

Abivax Announces Acceptance of Additional Late-Breaking Abstract from the ABTECT Phase 3 Induction Trials to be Presented at 2025 United European Gastroenterology (UEG) Meeting
Abivax announces acceptance of additional late-breaking abstract from the ABTECT Phase 3 induction trials to be presented at 2025 United European Gastroenterology (UEG) Meeting

Abivax Ulcerative Colitis Gastroenterology Late-breaking Abstract ABTECT Phase 3
BRIEF

published on 09/23/2025 at 22:10, 2 months 11 days ago

Abivax : Présentation de données prometteuses sur l'obefazimod au congrès 2025 de l'UEG

Abivax Obefazimod Rectocolite Hémorragique Phase 3 Congrès UEG
BRIEF

published on 09/23/2025 at 22:10, 2 months 11 days ago

Abivax: Presentation of promising data on obefazimod at the 2025 UEG congress

Abivax Obefazimod Ulcerative Colitis Phase 3 UEG Congress
PRESS RELEASE

published on 09/23/2025 at 22:05, 2 months 11 days ago

Abivax annonce la présentation des dernières données sur obefazimod issues des essais d'induction ABTECT de phase 3 à l'occasion du congrès 2025 de l’Union européenne de gastroentérologie
Abivax annonce la présentation des dernières données sur obefazimod lors du congrès 2025 de l’Union européenne de gastroentérologie. Analyse des essais d'induction ABTECT de phase 3. De nouveaux mécanismes dans la rectocolite hémorragique

Abivax Obefazimod Rectocolite Hémorragique Essais Cliniques UEG
PRESS RELEASE

published on 09/23/2025 at 22:05, 2 months 11 days ago

Abivax Announces Presentation of Late-Breaking Abstract for Obefazimod from the ABTECT Phase 3 Induction Trials at 2025 United European Gastroenterology (UEG) Meeting
Abivax announces presentation of late-breaking abstract for Obefazimod at 2025 United European Gastroenterology Meeting, showcasing potential as a new therapy for ulcerative colitis

Abivax Obefazimod Ulcerative Colitis Late-breaking Abstract UEG Meeting
BRIEF

published on 09/16/2025 at 18:05, 2 months 18 days ago

ABIVAX: Distribution of Share Capital and Voting Rights

Euronext Paris Share Capital Voting Rights AMF Abivax

Accesswire

Published on 12/05/2025 at 17:15, 17 minutes ago

TRX GOLD Attending the 3rd Annual DealFlow Discovery Conference
Published on 12/05/2025 at 17:00, 32 minutes ago

Three Trillion-Dollar Frontiers, One Technology: How SMX Is Everywhere at Once
Published on 12/05/2025 at 16:00, 1 hour 32 minutes ago

SMX Didn't Change Its Story; The World Finally Connected the Dots
Published on 12/05/2025 at 15:45, 1 hour 47 minutes ago

Critical Elements announce la clôture d'un placement privé de 7,0 $ million ca par voie de prise ferme
Published on 12/05/2025 at 15:45, 1 hour 47 minutes ago

Critical Elements Announces Closing of C$7.0 Million Bought Deal Life Private Placement

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 17:00, 32 minutes ago

EQS-Adhoc: The NAGA Group AG adjusts guidance for financial year 2025 following continued low volatility and weaker year-end performance
Published on 12/05/2025 at 16:25, 1 hour 7 minutes ago

4YFN26 Awards: Meet the Top 20 startups building the future
Published on 12/05/2025 at 16:10, 1 hour 22 minutes ago

Reorganization of the Eckert & Ziegler Executive Board
Published on 12/05/2025 at 16:00, 1 hour 32 minutes ago

EQS-Adhoc: TIN INN Holding AG implements financing strategy
Published on 12/05/2025 at 16:00, 1 hour 32 minutes ago

EQS-Adhoc: Amundi Physical Metals plc: Release of the Half-Year Financial Report as of September 30, 2025

Les Echos

Published on 12/05/2025 at 17:18, 14 minutes ago

La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
Published on 12/05/2025 at 17:18, 14 minutes ago

The video of the 2024-2025 results presentation meeting on December 5, 2025, is available
Published on 12/05/2025 at 15:10, 2 hours 21 minutes ago

Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 2 hours 21 minutes ago

Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 3 hours 34 minutes ago

RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE

View all LES ECHOS COMFI WIRE